COMP <GO>
TRXB vs ZURA // 10Y YIELD & FRED MACRO BETA
TRex Bio Inc. (NASDAQ) VS. Zura Bio Limited (Class A) (NASDAQ) • 15-METRIC TALLY: TRXB 2
— ZURA 0
■ METRIC PARITY
LAST: $13.52 (-6.31%) • MKT CAP: $371.1M
macro-sensitivity
—
LAST: $3.85 (-11.49%) • MKT CAP: $370.9M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRXB VS. ZURA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRXB | ZURA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -17.51% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.3 | 48.1 | +0.21 | TRXB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.1M | $370.9M | $212.8K | TRXB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRXB REV | ZURA REV | TRXB GROSS % | ZURA GROSS % | TRXB FCF | ZURA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$64.9M |
| FY 2024 | — | $0 | — | — | — | -$28.2M |
| FY 2023 | — | $0 | — | — | — | -$15.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRXB // BETA —
ZURA // BETA —